Please wait a minute...
European Journal of Gynaecological Oncology  2019, Vol. 40 Issue (2): 262-267    DOI: 10.12892/ejgo4399.2019
Original Research Previous articles | Next articles
Comparison of surgical outcomes between laparoscopy and laparotomy for early-stage ovarian cancer
Se Hyun Nam1, Woo Young Kim1, *()
1 Department of Obstetrics and Gynecology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
Download:  PDF(321KB)  ( 204 ) Full text   ( 9 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
To investigate the surgical and oncologic outcomes of laparoscopy compared with laparotomy in early-stage ovarian cancer, the authors reviewed medical records of patients with epithelial ovarian cancer at Kangbuk Samsung Hospital, Korea, between January 2001 and December 2014. Forty-nine patients were diagnosed with FIGO Stage I or II epithelial ovarian cancer and 25 and 24 patients underwent surgical staging by laparoscopy and laparotomy, respectively. Most of the clinicopathologic characteristics showed no statistical difference between the two groups. However, incidence of intraoperative tumor rupture was higher in the laparoscopy group (6/25 [24%] vs. 1/24 [4.2%]), although the primary tumor size was smaller (7.9 ± 4.2 vs. 15.0 ± 5.9, p = 0.05). There was no statistical difference between laparotomy and laparoscopy groups according to five-year overall survival (77.2% vs. 81.7%, p = 0.53) or five-year disease-free survival (76.5% vs. 81.3%, p = 0.77). Laparoscopic staging surgery showed similar surgical and oncologic outcomes to the laparotomy procedure in early-stage ovarian cancer.
Key words:  Laparoscopy      Laparotomy      Early-stage ovarian cancer      Survival     
Published:  10 April 2019     
*Corresponding Author(s):  WOO YOUNG KIM     E-mail:  obgykim@gmail.com

Cite this article: 

Se Hyun Nam, Woo Young Kim. Comparison of surgical outcomes between laparoscopy and laparotomy for early-stage ovarian cancer. European Journal of Gynaecological Oncology, 2019, 40(2): 262-267.

URL: 

https://ejgo.imrpress.com/EN/10.12892/ejgo4399.2019     OR     https://ejgo.imrpress.com/EN/Y2019/V40/I2/262

[1] Ji Geun Yoo, Hae Nam Lee, Sung Jong Lee, Jin Hwi Kim, Yong Seok Lee, Ahwon Lee, Soo Young Hur, Keun Ho Lee. Germline BRCA2 mutation is associated with greater progression-free survival in korean women with advanced high-grade serous ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 675-680.
[2] Silvia Ortega, José Angel Mínguez, José Manuel Aramendía, Marta Santisteban, Fernando Martinez-Regueira, Pablo Martí-Cruchaga, Juan Luis Alcázar, Matías Jurado. The impact of secondary cytoreductive surgery on survival in first recurrence of platinum sensitive epithelial ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 523-530.
[3] Jae Hong Sang, Soo-Ho Chung. Is it enough in ovarian cancer staging surgery to laparoscopic surgery? Comparison of surgical methods[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 541-544.
[4] Krittiya Somaketarin, Charuwan Tantipalakorn, Kittipat Charoenkwan, Prapaporn Suprasert, Jatupol Srisomboon. Survival outcomes of sex cord-stromal tumors of the ovary[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 563-568.
[5] Sigit Purbadi, Gregorius Tanamas, Lisa Novianti. Advanced stage ovarian cancer survival in Jakarta[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 587-590.
[6] Terumi Tanigawa, Maki Matoda, Yoichi Aoki, Hidetaka Nomura, Sanshiro Okamoto, Kohei Omatsu, Hiroyuki Kanao, Nobuhiro Takeshima. A case of recurrent smooth muscle tumor of uncertain malignant potential with abdominal dissemination after morcellation[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 648-650.
[7] Xiaofeng Xu, Xuan Zhou, Yijin Wang, Tao Liu, Jian Fu, Qian Yang, Jun Wu, Huaijun Zhou. Survival-associated transcriptome analysis in ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 455-461.
[8] Chenchen Zhu, Hanyuan Liu, Zhen Shen, Yanhu Xie, Tianjiao Zhang, Björn Nashan, Dabao Wu, Ying Zhou. Treatment and survival outcomes from epithelial ovarian cancer in women aged 65 years or older[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 415-421.
[9] M.E. Căpîlna, B. Szabo, J. Becsi, M. Morariu, M. Gheorghe, S.L. Kiss, B. Moldovan. Surgical complications and survival after pelvic exenteration: our experience following 60 procedures[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 171-175.
[10] Can Fang, Yan Zhao, Kezhen Li, Danhui Weng, Peng Wu, Gang Chen, Ding Ma, Juncheng Wei. Diabetes mellitus and epithelial ovarian cancer in Chinese women: a retrospective cohort study[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 260-264.
[11] S. Srdelić Mihalj, V. Čapkun, I. Kuzmić-Prusac. High-grade endometrial cancer survival (endometrioid to non-endometrioid histology comparison)[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 16-22.
[12] Z. Xu, H. Wen, Q. Xue. Successful pregnancy achieved by in vitro fertilization after fertility-preserving treatments in an infertile woman with borderline ovarian tumor and endometrial complex atypical hyperplasia: a case report[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 126-129.
[13] Y.-S. Kwon, K. S. Im, S. B. Yoo, W. I. Kim. Two cases of uterus-conserving treatment for early stage endometrial cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 145-147.
[14] S.H. Nam, H.R. Yang, D. Kang, K.O. Jung, W.Y. Kim. Survival of advanced epithelial ovarian/fallopian tube/primary peritoneum carcinoma after high-complexity upper abdominal surgery[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 970-976.
[15] Z. Zheng, Z.H. Han, Z.T. Li, X.H. Wu. The impact of laparoscopic surgical treatments on oncologic outcome of Stage I uterine leiomyosarcoma[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 977-981.
No Suggested Reading articles found!